An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
Conducting nuclear medicine imaging to compare pre- and post-treatment salivary gland function. The trial is managed by ComboTrial Consultancy Ltd. under Good Clinical Practice standards. Following ...